This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Magenta Therapeutics Dirección
Dirección controles de criterios 2/4
We currently do not have sufficient information about the CEO.
Información clave
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | no data |
Participación del CEO | n/a |
Permanencia media de la dirección | 2.8yrs |
Promedio de permanencia en la Junta Directiva | 5.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Magenta Therapeutics (NASDAQ:MGTA) In A Good Position To Invest In Growth?
Dec 10Magenta Therapeutics downgraded to neutral at Goldman Sachs on clarity over candidate
Aug 25Is Magenta Therapeutics (NASDAQ:MGTA) In A Good Position To Invest In Growth?
Jul 13Here's Why We're Not Too Worried About Magenta Therapeutics' (NASDAQ:MGTA) Cash Burn Situation
Apr 12Here's Why We're Not Too Worried About Magenta Therapeutics' (NASDAQ:MGTA) Cash Burn Situation
Dec 16Magenta Therapeutics (NASDAQ:MGTA) Is In A Good Position To Deliver On Growth Plans
Aug 26Magenta Therapeutics (MGTA) EHA Investor Presentations - Slideshow
Jun 18We're Not Very Worried About Magenta Therapeutics' (NASDAQ:MGTA) Cash Burn Rate
May 09Magenta Therapeutics EPS beats by $0.04
May 06What Kind Of Shareholders Hold The Majority In Magenta Therapeutics, Inc.'s (NASDAQ:MGTA) Shares?
Mar 17Magenta Therapeutics (NASDAQ:MGTA) Is In A Good Position To Deliver On Growth Plans
Jan 23Magenta Therapeutics announces expected 2021 highlights milestones
Jan 11What Kind Of Shareholders Hold The Majority In Magenta Therapeutics, Inc.'s (NASDAQ:MGTA) Shares?
Dec 01CEO
Magenta Therapeutics no tiene CEO, o no tenemos datos al respecto.
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 2.8yrs | US$1.12m | 0.029% $ 12.1k | |
Head of Investor Relations | no data | sin datos | sin datos | |
Chief Legal Officer & Secretary | 2.3yrs | US$2.09m | 0.033% $ 13.9k | |
Head of Clinical Development Operations | 5.5yrs | sin datos | sin datos | |
Senior Director of Investor Relations | no data | sin datos | sin datos |
2.8yrs
Permanencia media
Equipo directivo experimentado: MGTA's management team is considered experienced (2.8 years average tenure).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Independent Director | 6.9yrs | US$70.66k | 0.17% $ 71.3k | |
Independent Chairman | 2.8yrs | US$94.66k | 0% $ 0 | |
Member of Scientific Advisory Board | 4.3yrs | sin datos | sin datos | |
Independent Director | 7.6yrs | US$59.41k | 6.28% $ 2.7m | |
Independent Director | 4.3yrs | US$67.56k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Independent Director | 5.5yrs | US$58.57k | 0% $ 0 | |
Independent Director | 6.2yrs | US$64.41k | 0.0069% $ 2.9k | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Chair of Scientific Advisory Board & Director | 6.8yrs | US$119.41k | 0.38% $ 159.6k | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Member of Scientific Advisory Board | no data | sin datos | sin datos |
5.8yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: MGTA's board of directors are considered experienced (5.8 years average tenure).